Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 607.54 | 49.98 | 832.86 | ||
| High | 614.00 | 50.14 | 836.77 | ||
| Low | 602.87 | 49.18 | 825.55 | ||
| Latest | 602.77 | 49.51 | 835.65 | ||
| Change | -12.01 | -1.03 | -0.34 | ||
| % Change | -1.95% | -2.04% | -0.04% | ||
| Volume | 293,836 | 1,544,829 | 109,443 | ||
| 20-Day Average Volume | 1,098,064 | 3,258,120 | 308,180 | ||
| Previous Close | 614.78 | 50.54 | 835.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 671.04 | 50.71 | 808.40 | ||
| 20-Day Raw Stochastic | 3.39% | 1.21% | 80.29% | ||
| 20-Day Relative Strength | 29.74 | 36.90 | 56.78 | ||
| Weighted Alpha | +7.08 | +14.89 | +34.86 | ||
| Today's Opinion | 72% Sell | 40% Sell | 40% Buy | ||
| Previous Opinion | 72% Sell | 24% Sell | 40% Buy | ||
| Last Month's Opinion | 24% Sell | 40% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.95% since 05/22/26 | -4.15% since 05/22/26 | +2.97% since 05/22/26 | ||
| Low | 602.91 on 06/01/26 | 49.22 on 06/01/26 | 799.38 on 05/26/26 | ||
| High | 648.49 on 05/26/26 | 52.11 on 05/27/26 | 843.90 on 05/28/26 | ||
| 1-Month | |||||
| %Chg | -13.43% since 05/01/26 | -4.57% since 05/01/26 | +5.99% since 05/01/26 | ||
| Low | 602.91 on 06/01/26 | 49.22 on 06/01/26 | 775.62 on 05/19/26 | ||
| High | 730.59 on 05/13/26 | 52.11 on 05/27/26 | 843.90 on 05/28/26 | ||
| 3-Month | |||||
| %Chg | -22.32% since 02/27/26 | -16.71% since 02/27/26 | +8.28% since 02/27/26 | ||
| Low | 602.91 on 06/01/26 | 49.22 on 06/01/26 | 661.85 on 03/20/26 | ||
| High | 794.77 on 03/03/26 | 59.57 on 04/14/26 | 852.28 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | -19.05% since 12/01/25 | +4.37% since 12/01/25 | -7.20% since 12/01/25 | ||
| Low | 602.91 on 06/01/26 | 47.20 on 12/09/25 | 661.85 on 03/20/26 | ||
| High | 821.11 on 01/09/26 | 61.69 on 02/18/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 64,994,552 | 102,555,672 | 51,988,536 | ||
| Shares Outstanding, K | 105,720 | 2,029,198 | 62,188 | ||
| Annual Sales | 14,342,900,000 | 43,077,970,000 | 4,248,050,000 | ||
| Annual Net Income | 4,504,900,000 | 7,537,690,000 | 1,292,040,000 | ||
| Last Quarter Sales | 3,605,400,000 | 10,280,080,000 | 1,313,000,000 | ||
| Last Quarter Net Income | 727,200,000 | 2,340,610,000 | 366,000,000 | ||
| 60-Month Beta | 0.30 | 0.38 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 9.47 on 04/29/26 | 1.24 on 04/29/26 | 5.52 on 05/07/26 | ||
| Earnings Date | 08/07/26 | 07/29/26 | 07/30/26 | ||
| Most Recent Dividend | 0.940 on 05/20/26 | 0.454 on 05/15/26 | N/A | ||
| Next Ex-Dividends Date | 05/20/26 | 05/15/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 16.73 | 11.07 | 37.33 | ||